Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
about
SPINK1 protein expression and prostate cancer progression.p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasisHedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse modelEarly human prostate adenocarcinomas harbor androgen-independent cancer cellsp63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.Aberrant expression of katanin p60 in prostate cancer bone metastasisp53 Family: Role of Protein Isoforms in Human Cancer.Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature.α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up StudyDietary lycopene intake and risk of prostate cancer defined by ERG protein expressionp63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.Activation of invariant NK T cells in periodontitis lesions.Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.Expression of the cancer-testis antigen BORIS correlates with prostate cancer.Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?Immunohistochemical expression of heat shock proteins, p63 and androgen receptor in benign prostatic hyperplasia and prostatic carcinoma in the dog.Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.Family matters: sibling rivalry and bonding between p53 and p63 in cancer.p63 Expression is a prognostic factor in colorectal cancer.MYC overexpression at the protein and mRNA level and cancer outcomes among men treated with radical prostatectomy for prostate cancer.Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression.
P2860
Q34203149-6AFDB669-2124-4A9C-8A62-D2342E8F108EQ34273826-8CBE7549-10BF-433F-8643-46978D855842Q34515977-319F6CA4-AC58-45E2-8CD8-9749FE86773DQ35005020-E2C04AE2-868F-4170-9FB9-B4F42710BE95Q35227440-63EAA8AB-0084-4624-B174-50D959E6D5F4Q35230712-9437C30C-B40A-4D82-A45C-70FF392A964DQ35326348-E0231263-313D-4254-86D9-908488EA4CD5Q35582714-51CFBDF5-E08E-482A-9C01-5AC0D4ECF563Q35703906-36E72780-30F1-49AD-B0C3-FC382FE0D1F7Q36606672-88973355-8708-4920-A28D-4DA03E2C9181Q36694173-06895611-8F9B-4EB5-9767-18CF756C149CQ36750852-E651AF78-C1CD-4CA3-A0AA-3B28E9FBC8F0Q36782301-D6FADAFA-BD23-4FAE-984B-AB0DCC82F306Q37231116-D5E0259F-5CCE-4ADC-B5C7-B095F81F3F01Q37486567-37B79BF8-6D05-4566-8AA6-F9C16EF1E93BQ37634500-246A1071-D285-4D79-9B79-E9C300CE430BQ39079438-CE168C49-C165-4010-9AFC-5338D9CCDC67Q42438388-363D8ADE-9F3A-45D9-A1F2-1ABF4D923473Q42462891-BB55113D-0B2E-41CC-A237-046BE1E74496Q42503707-3252E95D-C91A-4D72-857F-3C97C582A9E2Q44053170-ED2AA156-5550-4911-A07F-AFF17241E151Q45075066-81D46F7F-4469-49AD-AAA4-051121D236BFQ47399099-617306B5-900A-43FC-9B3E-05EE31E8645BQ55470950-033BD318-ACD8-4FE9-BD83-DD77E9156D8D
P2860
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@en
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@nl
type
label
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@en
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@nl
prefLabel
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@en
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@nl
P2093
P2860
P50
P1476
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
@en
P2093
Alessandro Fornari
Julia Fleet
Marc Barry
Michelangelo Fiorentino
Preet K Dhillon
Sven Perner
P2860
P304
P356
10.1158/1055-9965.EPI-08-0785
P577
2009-01-20T00:00:00Z